As of November 2026 · checked against the official texts
Key points
- The EU MDR requires labels and instructions in the official Union language(s) set by the Member State of sale.
- Electronic instructions are allowed for professional-use devices under conditions; paper instructions are needed where lay use is foreseeable.
- In the United States required statements must be in English; in Korea the particulars must be in Korean.
In the EU, the label, instructions for use and other information supplied with the device must be in the official Union language(s) determined by the Member State where the device is made available (MDR Article 10(11)).
In the US, required label and labelling information must appear in English; if any foreign language is used, all required information must also appear in that language (21 CFR 801.15(c)).
In Korea, the particulars on containers, outer packaging and package inserts must be written accurately in Korean, in terms that are easy to read and understand (Medical Devices Act Article 23).
This page summarises, with article references, what manufacturers and importers need to know when deciding which documents to translate and into which languages.
At a glance
| EU regulation | Regulation (EU) 2017/745 (MDR), applying from 26 May 2021 (Article 123(2)) |
|---|---|
| EU labelling language | Official Union language(s) determined by the Member State of sale (Article 10(11)) |
| EU electronic IFU | Allowed for devices intended for professional users if the conditions of the implementing regulation, including a risk assessment, are met; paper IFU for lay persons where lay use is foreseeable (Implementing Regulation 2021/2226 as amended by 2025/1234) |
| Legacy-certificate devices | May be placed on the market until 31 December 2027 or 31 December 2028 if conditions are met (Article 120(3a)–(3b)) |
| United States | Required statements in English; the predominant language may be used for articles distributed solely in Puerto Rico or such Territories (21 CFR 801.15(c)) |
| Korea | Particulars in Korean (Medical Devices Act Article 23); package inserts on paper or electronic media, or a website for designated devices (Article 22(2)) |
EU: which language for labels and instructions?
Manufacturers must ensure that the device is accompanied by the information in Section 23 of Annex I in the official Union language(s) determined by the Member State in which the device is made available to the user or patient. Label particulars must be indelible, easily legible and clearly comprehensible to the intended user or patient (MDR Article 10(11)). Check the required language for each country of sale.
- Instructions for use written in terms readily understood by the intended user, supplemented with drawings and diagrams where appropriate (Annex I 23.1(a))
- Label information on the device itself, or on the packaging where that is not practicable (23.1(b))
- Instructions for use supplied with the device; class I and IIa devices that can be used safely without them are exempt (23.1(d))
- Symbols to conform to harmonised standards or common specifications, otherwise explained in the accompanying documentation (23.1(h))
EU: do the declaration of conformity and implant information need translation?
Yes. The EU declaration of conformity must be translated into the official Union language(s) required by the Member State(s) where the device is made available, and kept up to date (MDR Article 19(1)).
Manufacturers of implantable devices (other than those exempted by Article 18(3), such as sutures, staples and dental fillings) must provide identification details, warnings and precautions, expected lifetime and follow-up information for the patient, in the language(s) determined by the Member State, written so that a lay person readily understands it, with updates on the manufacturer's website. Identification details also go on the implant card delivered with the device (MDR Article 18(1)).
EU: which language for notified body documentation?
The Member State where the notified body is established may require that all or some documents, including technical documentation and audit, assessment and inspection reports, be in an official Union language it determines. Otherwise they may be in any official Union language acceptable to the notified body (MDR Article 52(12)). Confirm the language with the notified body before contracting.
EU: can instructions be electronic only (eIFU)?
The MDR allows non-paper instructions only to the extent and under the conditions set by implementing rules (Annex I 23.1(f)). Those rules are Implementing Regulation (EU) 2021/2226, widened by Implementing Regulation (EU) 2025/1234, in force from 16 July 2025.
- Devices intended for use by professional users may have electronic instead of paper instructions (2021/2226 Article 3(1), as amended), provided the conditions of the regulation are met, such as a documented risk assessment and paper copies on request at no extra cost
- Where use by lay persons is reasonably foreseeable, the instructions intended for lay persons must be provided on paper (Article 3(2), as amended)
Even with eIFU, keeping a print-ready PDF in each sales language is the safe practice.
How long can legacy MDD/AIMDD devices be sold?
Devices with a valid certificate under Directive 90/385/EEC or 93/42/EEC may be placed on the market until the following dates if the conditions are met (MDR Article 120(3a)):
- 31 December 2027: all class III devices and class IIb implantable devices (except sutures, staples, dental fillings, braces, crowns, screws, wedges, plates, wires, pins, clips and connectors)
- 31 December 2028: other class IIb devices, class IIa devices and class I devices placed on the market sterile or with a measuring function
- Devices that did not need a notified body under the Directive but do under the MDR: 31 December 2028 (Article 120(3b))
These dates apply only if, among other conditions, the devices continue to comply with the Directive, have no significant changes in design or intended purpose, and the manufacturer had a quality management system in place and lodged a formal application with a notified body by 26 May 2024 (Article 120(3c)). When labels, IFUs and declarations are revised for the MDR, every language version must be updated to match.
US FDA: must labels be in English only?
Required statements must appear in English. For articles distributed solely in Puerto Rico or a Territory where another language predominates, that language may be used instead (21 CFR 801.15(c)(1)(i)(B)).
- Stand-alone symbols must come from FDA-recognised or SDO standards and be explained in a symbols glossary included in the labelling, with an English statement of where it is (801.15(c)(1)(i)(D)–(E))
- If the label contains any foreign language, all required label information must also appear in that language (801.15(c)(2))
- If the labelling contains any foreign language, all required information must also appear in that language in the labelling (801.15(c)(3))
For multilingual labels, every language included must carry the complete required information, not a partial translation.
Korea: what must be in Korean for imported devices?
Manufacturers and importers must state on the container or outer packaging, among other items (Medical Devices Act Article 20):
- Name and address of the manufacturer or importer; for imports, the country and name of the original manufacturer
- Approval (certification or notification) number and the product, item and model names
- Lot number and date of manufacture (or expiry date), weight or packaging unit
- The words "medical device", "single use" and "do not reuse" for single-use devices, and the standard medical device code
- Where the package insert is provided on a website, that fact and the web address
Package inserts state directions for use and precautions, maintenance where needed, and other prescribed items. They may be supplied on electronic media such as USB or CD, as printed leaflets, or on a website for devices used mainly in medical institutions and designated by the Minister of Food and Drug Safety (Article 22).
These particulars must be placed where they are easy to see and written accurately in Korean, in terms that are easy to read and understand (Article 23). This is why a separate Korean package insert is prepared rather than using the foreign manufacturer's English IFU.
Checklist before ordering translation
- Confirm the countries of sale and the labelling language for each
- Fix the document set: labels, IFU, declaration of conformity, implant card and patient information
- Gather any existing translations and glossaries
Tell us the countries of sale and the documents, and we will set out the scope and schedule per language.
FAQ
Can EU instructions be in English only?
Only where the Member State of sale accepts English. The MDR requires the official Union language(s) determined by that Member State (Article 10(11)).
Can we supply electronic instructions only in the EU?
Yes for devices intended for professional users that meet the conditions of the implementing regulation (including a risk assessment), but paper instructions for lay persons are required where lay use is reasonably foreseeable (Implementing Regulation 2021/2226 Article 3, as amended by 2025/1234).
Can a US label include Korean as well?
Yes, but if a foreign language is used, all required information must also appear in that language (21 CFR 801.15(c)(2)–(3)).
Can an imported device use the English IFU in Korea?
No. The Medical Devices Act requires the particulars on containers, packaging and package inserts in Korean (Article 23). A Korean package insert is needed.
Does MDR transition mean retranslating everything?
Usually not. Translate only the revised source content into each language and keep existing terminology through the glossary.
Does Worldone assess regulatory compliance?
No. The manufacturer (and, where applicable, the notified body or authority) decides on applicability and compliance. Worldone Technical Translation translates, edits and manages the language versions of the documents.
How Worldone can help
- Instructions for use, labels and packaging text for medical and in vitro diagnostic devices
- EU declarations of conformity, implant cards and patient information, notified body documents
- Korean package inserts and labelling for imported devices
- Clinical and test reports, risk management and usability documents
- DTP: original layout, tables, drawings, warnings and symbols reproduced; print-ready PDF and source formats
- Revision management: only changed content translated, medical glossaries per language
Tell us the countries of sale and your documents, and we will set out the scope, schedule and quote per language.
Request a quoteRelated articles (in Korean)
- EU MDR과 IVDR은 무엇이 다른가? 2026-09-02
- EU MDR의 PMS·PMCF·PSUR 용어 정리 2026-08-14
- EU MDR에서 Serious Incident와 Side Effect는 어떻게 다른가? 2026-08-10
- 의료기기·바이오 문서 번역 시 자주 발생하는 오류|전문용어와 규제 문서 검수 2026-07-31
- 외국인 환자 200만 명 시대, 의료기관이 준비해야 할 다국어 의료문서 2026-10-15
Sources
- Regulation (EU) 2017/745 (MDR), consolidated text of 10 January 2025
- Implementing Regulation (EU) 2021/2226 (electronic instructions for use)
- Implementing Regulation (EU) 2025/1234 (amending 2021/2226)
- US 21 CFR 801.15 (prominence and language of required label statements)
- Medical Devices Act of Korea (National Law Information Center, current version)
This page summarises the legislation for guidance only and is not legal advice. Applicability and compliance are the responsibility of the manufacturer (and, where applicable, the notified body). Check the official texts for later amendments.
